Sign up to access historical data
Similar companies
| Company | Est. Transaction Value | |
|---|---|---|
 |
AmgenAMGN |
$42,000 |
 |
Editas MedicineEDIT |
-$8,000 |
 |
Alnylam PharmaceuticalsALNY |
$17,000 |
 |
United TherapeuticsUTHR |
-$210,000 |
 |
RegeneronREGN |
-$25,000 |
Trades by US Politicians
| Politician | Filing Date | Type | Size |
|---|---|---|---|
| Josh Gottheimer | Sep 25, 2024 | Buy | $1K - $15K |
Who is the latest politician to buy or sell Crinetics Pharmaceuticals shares?
Josh Gottheimer purchased Crinetics Pharmaceuticals shares most recently on September 25, 2024.
Which politician has bought the most CRNX stock in the last two years?
Josh Gottheimer has bought the most CRNX stock in the last 2 years, with an estimated value of $8,000.
What is the total value of politicians trading CRNX stock in the last 2 years?
According to our estimates, the net value of trades by US politicians for Crinetics Pharmaceuticals in the last 2 years is positive, amounting to $8,000. This indicates that US politicians have reasons to believe that the stock is going to go up.
How do insider transactions over the last 2 years reflect on Crinetics Pharmaceuticals' market confidence?
Over the last 2 years, insider transactions for Crinetics Pharmaceuticals have predominantly involved purchasing shares, indicating a strong confidence among insiders in the company's future prospects. This trend of more purchases than sales could be a positive signal to potential investors about the politicians view on the company's future and growth potential.
Why should individual investors pay attention to the stock transactions of US politicians?
Monitoring US politicians' stock trades is valuable because they may have inside information about upcoming policies that could affect stock values, providing investors with valuable clues for making informed decisions.
